Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Social Phobia Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Resident of Saskatchewan 2. Aged 18 years or older, either sex 3. Currently experiencing clinically significant symptoms of depression, anxiety, social phobia, and/or panic 4. Has regular access to a computer, Internet, and printer 5. Comfortable using the Internet and writing e-mails 6. In remission from any stage and any type of cancer as long as at least 1 month has passed since the completion of active treatment (radiation, chemotherapy, or surgery) but no longer than 18 months 7. Willing to have their physician, a medical clinical, or an emergency hospital be notified of participation in the program
Exclusion criteria
Exclusion criteria: 1. Not a resident of Saskatchewan 2. Less than 18 years of age 3. Has no regular access to a computer, Internet, and use of printer 4. Currently receiving psychotherapeutic treatment for anxiety or depression elsewhere or in some other form 5. Started a new psychotropic medication within the past month or had a change in dosage within the past month 6. Meets criteria for current substance abuse or dependence (drugs or alcohol) 7. Meets current criteria for a psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patient Health Questionnaire ? 9 Item 2. Generalized Anxiety Disorder ? 7 Item 3. Hospital Anxiety and Depression Scale These will be administered at baseline, post-treatment, and 3-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Medical Outcomes Study Short Form 2. Brief Pain Inventory 3. Fatigue Symptom Inventory 4. Short Health Anxiety Inventory 5. Treatment Satisfaction Questionnaire 6. Post-Treatment Program Check-List 7. Working Alliance Inventory 8. Client Feedback Open-Ended Questions (administered via telephone interview) Most measures are administered at baseline, post-treatment, and 3-month follow-up. Some are administered exclusively at post-treatment. Some measures are administered weekly. Baseline: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory Weekly: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Working Alliance Inventory (administered only at Week 5) Post-Treatment: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory, Treatment Satisfaction Questionnaire, Post-Treatment Program Check-List, Working Alliance Inventory, Client Feedback Open-Ended Questions 3-Month Follow-Up: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory | — |
Countries
Canada